Medtech Insight: 世界の医療機器・医療技術の最新情報
Coronavirus All FDA Inspections Of Chinese Manufacturing Facilities Come To Screeching Halt
In a late Friday news statement, agency head Stephen Hahn also warned of possible “shortages of critical medical products” The US agency has suspended all routine surveillance inspections in China through the end of March because of coronavirus fears, commissioner Stephen Hahn announced late on 14 February. Despite expecting medical product shortages, Hahn said the agency is being proactive: “We are not waiting for drug and device manufacturers to report shortages to us” before acting. The timing of Hahn’s statement – at 6 p.m. EST on a Friday, at the beginning of a three-day US holiday weekend – suggests he isn’t particularly excited to share the information.
製品説明＆デモお申込
お問い合わせ先
レポートストア
